Research
FORUM TRANSCRIPT

Biologic Manufacturing – Part 1 – Market Analysis & Postcoronavirus Outlook – 16 November 2021

  • Public Equity
  • Healthcare
  • Global
PREMIUM

Specialist

Former VP at CMC Biologics AS

Agenda

  • Recent trends and developments in biologic contract manufacturing and key players' competitive positioning across geographies
  • M&A and organic growth strategies and outsourcing trends
  • Growth expectations across microbial fermentation, mammalian cell cultures and CGT (cell and gene therapy)
  • Q4 2021 industry outlook and growth dynamics for large and small players

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo